The most effective treatments for eczema accomplish three things: They calm inflammation, bring relief from itch and restore ...

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best up and coming stocks with huge upside potential. On August 28, BofA ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate ...

Pediatricians share the best recommendations for dealing with eczema. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease that can cause significant discomfort for babies ...

Medically reviewed by Mary Choy, PharmD Eczema is a common skin condition that causes red, dry, and itchy patches of skin.

Delgocitinib is the first FDA-approved topical JAK inhibitor for moderate to severe chronic hand eczema in adults. The DELTA 1 and DELTA 2 studies showed significant efficacy, with improved patient ...

Eli Lilly said the Food and Drug Administration approved its treatment for moderate-to-severe eczema that isn't well controlled despite treatment with topical prescription therapies. The treatment, ...

LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate ...

ZORYVE is the number one prescribed branded topical therapy across three major inflammatory dermatoses combined—eczema, ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron ...

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...